Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$6.05 - $10.41 $508,200 - $874,440
-84,000 Closed
0 $0
Q2 2021

Oct 04, 2021

BUY
$6.66 - $10.92 $279,720 - $458,640
42,000 Added 100.0%
84,000 $828,000
Q1 2021

Oct 04, 2021

BUY
$4.59 - $18.74 $100,980 - $412,279
22,000 Added 110.0%
42,000 $392,000
Q4 2020

Oct 04, 2021

BUY
$3.93 - $5.5 $78,600 - $110,000
20,000 New
20,000 $96,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $362M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Jacob Asset Management Of New York LLC Portfolio

Follow Jacob Asset Management Of New York LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacob Asset Management Of New York LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jacob Asset Management Of New York LLC with notifications on news.